Particle embolization for hepatocellular carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Hepatocellular
  • Embolization, Therapeutic
  • Liver Neoplasms

abstract

  • Particle embolization for hepatocellular carcinoma is well tolerated and demonstrates actuarial survival of 50% at 1 year and 33% at 2 years.

publication date

  • September 28, 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9756073

Additional Document Info

start page

  • 822

end page

  • 8

volume

  • 9

number

  • 5